Characterization of Treatment Response to Recombinant Interferon-a2b in Osteosarcoma Xenografts
Journal Title: Journal of Computer Science & Systems Biology - Year 2009, Vol 1, Issue 2
Abstract
Interferons (IFNs) may target cancer cells both through their regulation of the immune response, effect on angiogenesis and through direct effect on cancer cells. Treatment response has been demonstrated in osteosarcoma patients, but tumour resistance to IFN-a is common. Hence, understanding the molecular mechanisms involved in response and resistance is essential for improving therapeutic efficacy. Of five xenografts screened for specific growth delay in response to treatment with unconjugated and PEGylated IFN-a2b, one displayed growth inhibition and tumour shrinkage. Growth inhibition increased on a dosing schedule of PEGylated IFN every third day. Xenografts resistant to PEGylated IFN were similarly resistant to unconjugated IFN. Combination treatment with IFN-a2b and doxorubicin resulted in improved growth control rates. Transcriptional profiling analysis of the one sensitive and two resistant xenografts identified a common set of 79 genes significantly affected by IFN-a2b treatment independent of tumour growth inhibition. All but four of the 79 genes were up-regulated. The majority of these genes were well characterized IFN-stimulated genes and core members of the IFN-a signalling pathway. The expression of a set of 128 unique genes changed only in the sensitive xenograft; 52/128 genes were up-regulated. The specific geneexpression pattern seen in the responsive xenograft identified possible pathways important for the antitumor effect of IFN-a in osteosarcoma, including ssubsets of genes involved in cell adhesion and osteogenic tissue development. The observed improved control rates of combined treatment with IFN and doxorubicin are encouraging and should be further explored.
Authors and Affiliations
Heidi Namløs, Christoph Müller, Johan Bjerner, Ola Myklebost, Ingrid Østensen, Sigbjørn Smeland, Gunnar Sæter, Øyvind Bruland
Keywords
Related Articles
- EP ID EP96958
- DOI 10.4172/ 1948-5956.1000018
- Views 62
- Downloads 0
ANNA-3 Associated Stiff-Person-Syndrome
Genes Encoding Enzymatic Activities Implicated in the Eicosanoid Cascade of Arachidonic Acid and their Receptors are Expressed at mRNA Levels in Human Meningiomas
In view of the important oncogenic action of lipoxygenase (LOX) and cycloxygenase (COX) enzymatic activities we investigated, by using real time PCR, their presence in human meningiomas. Results indicated the presence of...
Larynx Preserving Treatments in the Early and Advanced Laryngeal Cancers; A Retrospective Analysis
Background: To assess tumor control and survival of the patients with laryngeal cancers who received chemoradiation or radiotherapy alone as definitive treatment. Material and methods: Patients with laryngeal cancers wh...
The Effect of Energy Healing on in vitro Tumour Cells Proliferation Cell Cycle and Apoptosis-an Experimental Study
In this paper, we examined the ability of healing, involving subtle energy fields in and around the practitioner’s body for medical purposes to damage cancer cells in vitro. Contact treatments by Reiki practitioners were...
Characterization of Treatment Response to Recombinant Interferon-a2b in Osteosarcoma Xenografts
Interferons (IFNs) may target cancer cells both through their regulation of the immune response, effect on angiogenesis and through direct effect on cancer cells. Treatment response has been demonstrated in osteosarcoma...